Skip to main content

Methocarbamol

NDC 85509-1341 · PHOENIX RX LLC

Generic nameMethocarbamol
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)METHOCARBAMOL
Strength750 mg/1
Pharmacologic classCentrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
Marketing categoryANDA

Packages

85509-1341-3 — 30 TABLET, FILM COATED in 1 BOTTLE (85509-1341-3)

85509-1341-6 — 60 TABLET, FILM COATED in 1 BOTTLE (85509-1341-6)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

80425-0578 — Methocarbamol Tablets, 80425-0579 — Methocarbamol Tablets, 82461-722 — Methocarbamol, 82461-723 — Methocarbamol, 82804-121 — methocarbamol, 82804-273 — methocarbamol, 82804-954 — methocarbamol, 82804-955 — methocarbamol, 82982-038 — Methocarbamol Tablets, 85477-101 — Methocarbamol, 85509-1770 — Methocarbamol Tablets, 85509-1910 — methocarbamol, 85509-2910 — methocarbamol, 85534-0021 — methocarbamol, 85534-0022 — methocarbamol, 85534-0057 — methocarbamol, 85766-060 — Methocarbamol, 86211-114 — Methocarbamol, 87063-040 — Methocarbamol, 87063-041 — Methocarbamol, +188 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels